LSM11 Antikörper (AA 1-141)
-
- Target Alle LSM11 Antikörper anzeigen
- LSM11 (LSM11, U7 Small Nuclear RNA Associated (LSM11))
-
Bindungsspezifität
- AA 1-141
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LSM11 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunofluorescence (IF)
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human U7 snRNA-associated Sm-like protein LSm11 protein (1-141AA)
- Isotyp
- IgG
-
-
- Applikationshinweise
- Recommended dilution: WB:1:500-1:5000, IF:1:20-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- LSM11 (LSM11, U7 Small Nuclear RNA Associated (LSM11))
- Andere Bezeichnung
- LSM11 (LSM11 Produkte)
- Synonyme
- 2210404M20Rik antikoerper, AV079530 antikoerper, LSM11, U7 small nuclear RNA associated antikoerper, U7 snRNP-specific Sm-like protein LSM11 antikoerper, LSM11 antikoerper, Lsm11 antikoerper
- Hintergrund
-
Background: Component of the U7 snRNP complex that is involved in the histone 3\'-end pre-mRNA processing (By similarity). Increases U7 snRNA levels but not histone 3\'-end pre-mRNA processing activity, when overexpressed. Required for cell cycle progression from G1 to S phases. Binds specifically to the Sm-binding site of U7 snRNA.
Aliases: LSM11U7 snRNA-associated Sm-like protein LSm11 antibody
- UniProt
- P83369
-